SMAD4 and familial pancreatic carcinoma: Through rapid autopsies from pancreatic cancer patients, Yachida S et al. [54] and Iacobuzio-Donahue CA et al. [55] found that SMAD4 is inactivated during subclonal evolution and metastatic progression, but is not associated with locally destructive tumors.